Stock kasuwa, musayar ciniki a yau
Rahoton samfurori na kamfanonin 71229 a ainihin lokacin.
Stock kasuwa, musayar ciniki a yau

Rahoton samfurori

Stock ya faɗi a kan layi

Stock ya faɗi tarihi

Kasashen kasuwancin jari

Stock dividends

Riba daga kamfanin kamfanoni

Rahotan kuɗi

Ƙididdiga na kamfanoni. A ina zan zuba kudi?

Armata Pharmaceuticals, Inc. kasuwar kasuwa

Matsayin kasuwancin jari na Armata Pharmaceuticals, Inc. a yau da kuma tarihin ƙaddamar da Armata Pharmaceuticals, Inc. daga farkon kasuwanci a ARMP hannun jari akan musayar jari.
Ƙara zuwa widget din
Ƙara zuwa widget din

Armata Pharmaceuticals, Inc. girma

Yau kasuwa kasuwa na Armata Pharmaceuticals, Inc. shine 55 662 836 US dollar.
+1 192 776 $ (+2.19%)
canji na strongn kudi tun jiya

Armata Pharmaceuticals, Inc. karuwancin kasuwa a daloli yau. Armata Pharmaceuticals, Inc. ikon mallakar kasuwa shine jimlar dukkan Armata Pharmaceuticals, Inc. abubuwan fitar da akalar aka bayar. Kuna iya gano Armata Pharmaceuticals, Inc. capitalization na yau dangane da ciniki na wannan abin da aka ambata kan kasuwar musayar jari. Armata Pharmaceuticals, Inc. capitalization = 55 662 836 dalar Amurka.

Armata Pharmaceuticals, Inc. girma na kasuwanci

Yau yaudarar kasuwancin jari Armata Pharmaceuticals, Inc. ya kai 3 003 US dollar.
-4 871 $ (-61.86%)
canjin karuwar kasuwancin tun jiya

Armata Pharmaceuticals, Inc. kundin ciniki na yau = = 3 003 dalar Amurka. Armata Pharmaceuticals, Inc. an yi ciniki akan musayar jari daban-daban. Shafin yau da kullun na Armata Pharmaceuticals, Inc. an gabatar da girman ciniki a shafin yanar gizon mu. Armata Pharmaceuticals, Inc. karuwanci ya girma ta $ 1 192 776.

Nuna:
To

Armata Pharmaceuticals, Inc. kasuwar kasuwa

Armata Pharmaceuticals, Inc. karfafan kasuwanni akan jadawali cikin shekaru. Canjin Armata Pharmaceuticals, Inc. ikon mallaka a mako guda shine -6.1%. 0% a kowace shekara - wani canji a cikin kasuwar kasuwancin Armata Pharmaceuticals, Inc.. A yau, Armata Pharmaceuticals, Inc. ikon mallaka daidai yake da 55 662 836 dalar Amurka.

Week Watan 3 months Shekara 3 shekaru

Armata Pharmaceuticals, Inc. tarihin lalata

Kwanan Girma
Babban jari (kasuwannin kasuwa) shine kasuwa na kasuwa na kamfanonin da ke sayarwa akan musayar jari. Mahimmancin kasuwancin yana daidai da farashin hannun jari da yawa ta hanyar yawan kuɗi.
03/05/2023 55 662 836 $
02/05/2023 54 470 060 $
01/05/2023 56 385 728 $
28/04/2023 58 554 416 $
27/04/2023 56 024 284 $
26/04/2023 57 419 472 $
25/04/2023 59 277 308 $

Armata Pharmaceuticals, Inc. tashar girma

Week Watan 3 months Shekara 3 shekaru

Armata Pharmaceuticals, Inc. bayanan tarihi na tarihi

Kwanan Volume (24h)
Ƙaramar kasuwancin Armata Pharmaceuticals, Inc. hannun jari shine yawan yawan ma'amaloli tare da hannun jari na ARMP da aka saya a lokacin da aka zaba.
03/05/2023 3 003 $
02/05/2023 7 874 $
01/05/2023 494 $
28/04/2023 585 $
27/04/2023 9 818 $
26/04/2023 1 434 $
25/04/2023 1 112 $

Armata Pharmaceuticals, Inc. karfaffen kaya ya kasance zuwa 55 662 836 Dalar Amurka a 03/05/2023. Armata Pharmaceuticals, Inc. karuwancin kasuwa a 02/05/2023 yayi daidai da 54 470 060 dalar Amurka. Babban tsarin kasuwancin Armata Pharmaceuticals, Inc. a 01/05/2023 wanda aka kimanta zuwa 56 385 728 dalar Amurka. Armata Pharmaceuticals, Inc. capitalization daidai yake da 58 554 416 Dalar Amurka a 28/04/2023.

Kasuwancin kasuwa na Armata Pharmaceuticals, Inc. wanda aka ƙira zuwa 56 024 284 Dalar Amurka a 27/04/2023. Armata Pharmaceuticals, Inc. karfaffen kaya ya kasance zuwa 57 419 472 Dalar Amurka a 26/04/2023. A 25/04/2023, Armata Pharmaceuticals, Inc. taken kasuwa shine $ 59 277 308.

A capitalization na Armata Pharmaceuticals, Inc. a yau shi ne 55 662 836 $. Girman kasuwa na Armata Pharmaceuticals, Inc. ya canza zuwa +2.19% idan aka kwatanta da jiya. Hanyoyin ciniki na ARMP hannun jari na Armata Pharmaceuticals, Inc. a rana ta ƙarshe ta kasuwanci ya kasance 3 003 $. Ƙarin ciniki na Armata Pharmaceuticals, Inc. ya canza zuwa -61.862% idan aka kwatanta da ranar ciniki.

Kudin hannun jari Armata Pharmaceuticals, Inc.

Finance Armata Pharmaceuticals, Inc.